Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Favipiravir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 535Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir
    Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir

    07 Dec 2022

    // CLINICALTRIALSARENA

    https://www.clinicaltrialsarena.com/news/tetra-bio-pharma-trial-ards-003-favipiravir/

    CLINICALTRIALSARENA
    07 Dec 2022
    Share Share
    Appili Therapeutics Provides Update Ph3 PRESECO Clinical Trial Evaluating Avigan
    Appili Therapeutics Provides Update Ph3 PRESECO Clinical Trial Evaluating Avigan

    14 Oct 2022

    // APPILITHERAPEUTICS

    https://www.appilitherapeutics.com/newsfeed/Appili-Therapeutics-Provides-Update-on-Phase-3-PRESECO-Clinical-Trial-Evaluating-Avigan%C2%AE%2FReeqonus%E2%84%A2

    APPILITHERAPEUTICS
    14 Oct 2022
    Share Share
    Japan's Fujifilm stops work on Avigan as COVID drug
    Japan's Fujifilm stops work on Avigan as COVID drug

    14 Oct 2022

    // HEALTH ET

    https://health.economictimes.indiatimes.com/news/pharma/japans-fujifilm-stops-work-on-avigan-as-covid-drug/94857805

    HEALTH ET
    14 Oct 2022
    Share Share
    Fujifilm terminates P III enrollment for Avigan drug trial in Japan
    Fujifilm terminates P III enrollment for Avigan drug trial in Japan

    15 Mar 2022

    // BIOSPECTRUMASIA

    https://www.biospectrumasia.com/news/25/19862/fujifilm-terminates-ph-iii-enrolment-for-avigan-drug-trial-in-japan-due-to-omicron-variant.html

    BIOSPECTRUMASIA
    15 Mar 2022
    Share Share
    Egis Favipiravir Drug Licenced for Covid-19 Treatment
    Egis Favipiravir Drug Licenced for Covid-19 Treatment

    20 Dec 2021

    // HUNGARYTODAY

    https://hungarytoday.hu/coronavirus-egis-favipiravir-drug-licenced-covid-19-treatment/

    HUNGARYTODAY
    20 Dec 2021
    Share Share
    Dr. Reddy’s API team is a 2021 winner in – API Supplier year at Global generics
    Dr. Reddy’s API team is a 2021 winner in – API Supplier year at Global generics

    11 Nov 2021

    // PRESS RELEASE

    https://api.drreddys.com/news/dr-reddys-api-team-2021-winner-api-supplier-year-global-generics-biosimilars-awards

    PRESS RELEASE
    11 Nov 2021
    Share Share